早产儿和极低出生体重婴儿启动益生菌的最佳时间:在单一新生儿重症监护病房的10年经验。

JeongHoon Park, Jae Young Cho, Jung Sook Yeom, Jin Su Jun, Ji Sook Park, Eun Sil Park, Ji Hyun Seo, Jae Young Lim, Chan-Hoo Park, Hyang-Ok Woo
{"title":"早产儿和极低出生体重婴儿启动益生菌的最佳时间:在单一新生儿重症监护病房的10年经验。","authors":"JeongHoon Park,&nbsp;Jae Young Cho,&nbsp;Jung Sook Yeom,&nbsp;Jin Su Jun,&nbsp;Ji Sook Park,&nbsp;Eun Sil Park,&nbsp;Ji Hyun Seo,&nbsp;Jae Young Lim,&nbsp;Chan-Hoo Park,&nbsp;Hyang-Ok Woo","doi":"10.5223/pghn.2023.26.3.146","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The starting time for probiotic supplementation in preterm infants after birth varies widely. This study aimed to investigate the optimal time for initiating probiotics to reduce adverse outcomes in preterm or very low birth weight (VLBW) infants.</p><p><strong>Methods: </strong>Medical records of preterm infants born at a gestational age (GA) of <32 weeks or VLBW infants in 2011-2020 were reviewed respectively. The infants who received <i>Saccharomyces boulardii</i> probiotics within 7 days of birth were grouped into an early introduction (EI) group, and those who received supplemented probiotics after 7 days of birth were part of the late introduction (LI) group. Clinical characteristics were compared between the two groups and analyzed statistically.</p><p><strong>Results: </strong>A total of 370 infants were included. The mean GA (29.1 weeks vs. 31.2 weeks, <i>p</i><0.001) and birth weight (1,235.9 g vs. 1491.4 g, <i>p</i><0.001) were lower in the LI group (n=223) than in the EI group. The multivariate analysis indicated that factors affecting the LI of probiotics were GA at birth (odds ratio [OR], 1.52; <i>p</i><0.001) and the enteral nutrition start day (OR, 1.47; <i>p</i><0.001). The late probiotic introduction was associated with a risk of late-onset sepsis (OR, 2.85; <i>p</i>=0.020), delayed full enteral nutrition (OR, 5.44; <i>p</i><0.001), and extrauterine growth restriction (OR, 1.67; <i>p</i>=0.033) on multivariate analyses after adjusting for GA.</p><p><strong>Conclusion: </strong>Early supplementation of probiotics within a week after birth may reduce adverse outcomes among preterm or VLBW infants.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/0e/pghn-26-146.PMC10192591.pdf","citationCount":"0","resultStr":"{\"title\":\"The Optimal Time for Initiating Probiotics for Preterm and Very-Low-Birth-Weight Infants: A 10-Year Experience in a Single Neonatal Intensive Care Unit.\",\"authors\":\"JeongHoon Park,&nbsp;Jae Young Cho,&nbsp;Jung Sook Yeom,&nbsp;Jin Su Jun,&nbsp;Ji Sook Park,&nbsp;Eun Sil Park,&nbsp;Ji Hyun Seo,&nbsp;Jae Young Lim,&nbsp;Chan-Hoo Park,&nbsp;Hyang-Ok Woo\",\"doi\":\"10.5223/pghn.2023.26.3.146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The starting time for probiotic supplementation in preterm infants after birth varies widely. This study aimed to investigate the optimal time for initiating probiotics to reduce adverse outcomes in preterm or very low birth weight (VLBW) infants.</p><p><strong>Methods: </strong>Medical records of preterm infants born at a gestational age (GA) of <32 weeks or VLBW infants in 2011-2020 were reviewed respectively. The infants who received <i>Saccharomyces boulardii</i> probiotics within 7 days of birth were grouped into an early introduction (EI) group, and those who received supplemented probiotics after 7 days of birth were part of the late introduction (LI) group. Clinical characteristics were compared between the two groups and analyzed statistically.</p><p><strong>Results: </strong>A total of 370 infants were included. The mean GA (29.1 weeks vs. 31.2 weeks, <i>p</i><0.001) and birth weight (1,235.9 g vs. 1491.4 g, <i>p</i><0.001) were lower in the LI group (n=223) than in the EI group. The multivariate analysis indicated that factors affecting the LI of probiotics were GA at birth (odds ratio [OR], 1.52; <i>p</i><0.001) and the enteral nutrition start day (OR, 1.47; <i>p</i><0.001). The late probiotic introduction was associated with a risk of late-onset sepsis (OR, 2.85; <i>p</i>=0.020), delayed full enteral nutrition (OR, 5.44; <i>p</i><0.001), and extrauterine growth restriction (OR, 1.67; <i>p</i>=0.033) on multivariate analyses after adjusting for GA.</p><p><strong>Conclusion: </strong>Early supplementation of probiotics within a week after birth may reduce adverse outcomes among preterm or VLBW infants.</p>\",\"PeriodicalId\":19989,\"journal\":{\"name\":\"Pediatric Gastroenterology, Hepatology & Nutrition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/0e/pghn-26-146.PMC10192591.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Gastroenterology, Hepatology & Nutrition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5223/pghn.2023.26.3.146\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Gastroenterology, Hepatology & Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5223/pghn.2023.26.3.146","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

目的:早产儿出生后开始补充益生菌的时间差异很大。本研究旨在探讨启动益生菌的最佳时间,以减少早产儿或极低出生体重(VLBW)婴儿的不良后果。方法:将出生7天内出生的博氏酵母菌益生菌的胎龄(GA)早产儿分为早期引入(EI)组,出生7天后补充益生菌的早产儿为晚期引入(LI)组。比较两组患者的临床特征并进行统计学分析。结果:共纳入370例婴儿。平均GA(29.1周vs. 31.2周,ppppp=0.020),延迟完全肠内营养(OR, 5.44;pp=0.033)。结论:出生后一周内早期补充益生菌可以减少早产儿或VLBW婴儿的不良后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Optimal Time for Initiating Probiotics for Preterm and Very-Low-Birth-Weight Infants: A 10-Year Experience in a Single Neonatal Intensive Care Unit.

Purpose: The starting time for probiotic supplementation in preterm infants after birth varies widely. This study aimed to investigate the optimal time for initiating probiotics to reduce adverse outcomes in preterm or very low birth weight (VLBW) infants.

Methods: Medical records of preterm infants born at a gestational age (GA) of <32 weeks or VLBW infants in 2011-2020 were reviewed respectively. The infants who received Saccharomyces boulardii probiotics within 7 days of birth were grouped into an early introduction (EI) group, and those who received supplemented probiotics after 7 days of birth were part of the late introduction (LI) group. Clinical characteristics were compared between the two groups and analyzed statistically.

Results: A total of 370 infants were included. The mean GA (29.1 weeks vs. 31.2 weeks, p<0.001) and birth weight (1,235.9 g vs. 1491.4 g, p<0.001) were lower in the LI group (n=223) than in the EI group. The multivariate analysis indicated that factors affecting the LI of probiotics were GA at birth (odds ratio [OR], 1.52; p<0.001) and the enteral nutrition start day (OR, 1.47; p<0.001). The late probiotic introduction was associated with a risk of late-onset sepsis (OR, 2.85; p=0.020), delayed full enteral nutrition (OR, 5.44; p<0.001), and extrauterine growth restriction (OR, 1.67; p=0.033) on multivariate analyses after adjusting for GA.

Conclusion: Early supplementation of probiotics within a week after birth may reduce adverse outcomes among preterm or VLBW infants.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
43
期刊介绍: Pediatric Gastroenterology, Hepatology and Nutrition (Pediatr Gastroenterol Hepatol Nutr), an official journal of The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition, is issued bimonthly and published in English. The aim of Pediatr Gastroenterol Hepatol Nutr is to advance scientific knowledge and promote child healthcare by publishing high-quality empirical and theoretical studies and providing a recently updated knowledge to those practitioners and scholars in the field of pediatric gastroenterology, hepatology and nutrition. Pediatr Gastroenterol Hepatol Nutr publishes review articles, original articles, and case reports. All of the submitted papers are peer-reviewed. The journal covers basic and clinical researches on molecular and cellular biology, pathophysiology, epidemiology, diagnosis, and treatment of all aspects of pediatric gastrointestinal diseases and nutritional health problems.
期刊最新文献
Association between Transfusion-Related Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study. Benefits and Risks of Preprepared Parenteral Nutrition for Early Amino Acid Administration in Premature Infants with Very Low Birth Weight. Combined Predictors of Long-Term Outcomes of Kasai Surgery in Infants with Biliary Atresia. Current Pediatric Endoscopy Training Situation in the Asia-Pacific Region: A Collaborative Survey by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition Endoscopy Scientific Subcommittee. Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1